1.
Papp K, Szepietowski J, Kircik L, Toth D, Kuligowski M, Venturanza M, Sun K, Simpson E. Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies. J of Skin [Internet]. 2021 Jan. 1 [cited 2024 Jul. 3];5(1):s8. Available from: https://jofskin.org/33014/index.php/skin/article/view/1161